Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Learn which no annual fee rewards credit cards stand out as the best options. Choose wisely for maximum benefits!
24,006 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
A new GROK AI forecast linked to Elon Musk projects XRP could surge to several dollars by 2026, contingent on regulat...
A fresh BIT report shows the long-standing links between stocks, gold, and Bitcoin breaking down as investors chase s...
Bitcoin teeters near a critical support zone after a pullback from last week’s highs. This bitcoin price analysis: co...
Jim Cramer's ongoing Nvidia purchases rest on one core belief: the CUDA software moat that underpins Nvidia's AI lead...
Google Gemini AI projects a sharp, liquidity-driven Bitcoin rally to as high as $150,000 by the end of 2026, undersco...
Korean chip equities are wavering after a blistering AI-driven rally, with the KOSPI retreating and memory peers weig...
Gas prices swung in 2026 amid Middle East tensions, lifting refining margins. This article identifies the stocks pois...
Cellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
Twenty-six Meta employees claim AI-assisted layoff decisions targeted staff on medical or family leave. The suit seek...
Stocks and exchange-traded funds tied to PayPal surged after Reuters reported Stripe and Advent International were we...
AI-driven demand and memory shortages could propel Micron to new highs by late 2027. This article lays out why a big ...